Health Care Originals Wins Top Honors at SuperCrowdLA Pitch Competition with AI Respiratory Technology
TL;DR
Health Care Originals wins top honors in Live Pitch Competition at SuperCrowdLA, showcasing AI-powered technology for respiratory monitoring.
Health Care Originals CEO Sharon Samjitsingh's pitch highlights breakthrough AI-powered respiratory monitoring technology at SuperCrowdLA event.
Health Care Originals' AI-powered wearable could transform the lives of millions managing chronic respiratory conditions, improving global respiratory health.
Judges' Choice and SuperCrowd Award winners Health Care Originals receive prizes to accelerate growth and impact, showcasing innovative solutions at SuperCrowdLA.
Found this article helpful?
Share it with your network and spread the knowledge!
Health Care Originals, a healthcare technology startup, emerged as the standout winner at this year's SuperCrowdLA Live Pitch Competition, capturing both the Judges' Choice and Audience Choice Awards. The company's CEO, Sharon Samjitsingh, presented an AI-powered wearable technology designed to revolutionize respiratory health monitoring for chronic conditions such as asthma and COPD.
The victory comes with a comprehensive prize package valued at over $15,000, including a VIP membership in Green2Gold impact incubator, a legal consultation with Manatt, Phelps & Phillips, LLP, and a marketing strategy consultation with Digital Niche Agency. These resources are specifically targeted to accelerate the company's growth and market potential.
The competition's judging panel, which included industry experts Jason Fishman, Léa Bouhelier-Gautreau, and Matt Warnock, recognized the significant potential of Health Care Originals' technology to address critical healthcare challenges. Devin Thorpe, CEO of The Super Crowd, Inc., emphasized the broader implications of the technology, noting its potential to transform the lives of millions managing respiratory conditions.
By winning both prestigious awards, Health Care Originals has positioned itself as a promising innovator in the healthcare technology sector. The dual recognition signals strong market validation and investor interest in solutions that leverage artificial intelligence to improve chronic disease management and patient outcomes.
Curated from 24-7 Press Release
